HLTH - VanEck Vectors Global Healthcare Leaders ETF (AU0000102683)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

(%)

AU0000102683

HLTH ISIN

Exchange Traded Funds (ETF)

Fondstyp

VanEck

Anbieter

11,59 AUD

NAV pro Aktie | 10/07/2026

08/09/2020

Startdatum

1 Wiederholungen pro Jahr

Ausschüttung von Dividenden

CEXXXU

CFI

HLTH

Ticker

Formed

Status

Equity

Investitionsobjekt

Healthcare

Sektor

Developed markets

Geographie

MarketGrader Developed Markets (ex-Australia) Health Care Index

Benchmark

0.45 %

Gesamtkostenquote

51,66 Mio. AUD

Gesamtes Fondsvermögen | 10/07/2026

51,66 Mio. AUD

Aktien-Anlageklasse Volumen | 10/07/2026

Nein

UCITS

Rendite auf 13/07/2026, Australian S.E.

YTD

-10,9 %
1M

-3,57 %
3M

-8,95 %
6M

-13,4 %
1J

-4,26 %
3J

4,5 %
5J

6,6 %
10J

-

Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum

Zum Vergleichen hinzufügen

Kurse (HLTH)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

175 910

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

HLTH profile

The VanEck Vectors Global Healthcare Leaders ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Developed markets. The VanEck fund’s base currency is AUD and the share class was registered 08.09.2020 with unique ISIN - AU0000102683. Main exchange is Australian S.E. and ticker symbol is HLTH. The total expense ratio is 0.45%. The VanEck Vectors Global Healthcare Leaders ETF pays dividends 1 time(s) per year.

Struktur HLTH auf 13/07/2026

Struktur in Excel herunterladen

Wertpapier	Wertpapier
Illumina Inc	3,11%
West Pharmaceutical Services Inc	2,92%
Arrowhead Pharmaceuticals Inc	2,7%
Exelixis Inc	2,66%
Neurocrine Biosciences Inc	2,65%
Novo Nordisk A/S	2,53%
Ypsomed Holding Ag	2,46%
Incyte Corp	2,45%
Argenx Se	2,43%
Eli Lilly & Co	2,34%
Halozyme Therapeutics Inc	2,32%
Dexcom Inc	2,27%
Alk-Abello A/S	2,24%
Kyowa Kirin Co Ltd	2,17%
Teva Pharmaceutical Industries Ltd	2,17%
Encompass Health Corp	2,13%
Merck & Co Inc	2,08%
Ipsen Sa	2,07%
Johnson & Johnson	2,07%
Vertex Pharmaceuticals Inc	2,01%
Fisher & Paykel Healthcare Corp Ltd	1,99%
United Therapeutics Corp	1,98%
Otsuka Holdings Co Ltd	1,95%
Orion Oyj	1,94%
Amgen Inc	1,93%
Idexx Laboratories Inc	1,91%
Stryker Corp	1,9%
Gsk Plc	1,9%
Bristol-Myers Squibb Co	1,89%
Daiichi Sankyo Co Ltd	1,85%
Alnylam Pharmaceuticals Inc	1,85%
Ucb Sa	1,84%
Penumbra Inc	1,84%
Globus Medical Inc	1,79%
Astrazeneca Plc	1,78%
Hoya Corp	1,74%
Astellas Pharma Inc	1,74%
Tenet Healthcare Corp	1,74%
Alteogen Inc	1,73%
Resmed Inc	1,71%
Samsung Biologics Co Ltd	1,69%
Intuitive Surgical Inc	1,67%
Sk Biopharmaceuticals Co Ltd	1,63%
Shionogi & Co Ltd	1,59%
Universal Health Services Inc	1,57%
Ensign Group Inc/The	1,56%
Chugai Pharmaceutical Co Ltd	1,52%
Insulet Corp	1,42%
Zoetis Inc	1,27%
Boston Scientific Corp	1,26%
Other/Cash	0,05%

Alle anzeigen Verstecken

Andere - %

HLTH - VanEck Vectors Global Healthcare Leaders ETF (AU0000102683)

Rendite auf 13/07/2026, Australian S.E.

Kurse (HLTH)

Kurs-Dynamik

HLTH profile

Struktur HLTH auf 13/07/2026

Einkommens-Zahlung (AU0000102683)

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds